ARD

What ARD does

ARD (Agro-industrie Recherches et Développements) is a French industrial biotechnology company founded in 1989 and headquartered at the Pomacle-Bazancourt biorefinery in northeastern France, operating as a wholly-owned subsidiary of the VIVESCIA Industries agricultural cooperative group. The company specializes in white biotechnologies (industrial fermentation using natural and engineered bacterial strains), green chemistry, and plant extraction, providing services that bridge the gap between laboratory-scale R&D and full industrial-scale bioproduction. Its core assets include a complete TRL chain on a single site — from 2L laboratory fermenters through a 2,000 m² pilot hall (2-10 m³ fermenters, 1-9 m³ chemical reactors) to the BioDémo industrial demonstration platform with 180-350 m³ fermenters operating 24/7 — making it one of the few European open-innovation platforms of this scale.

ARD's product portfolio spans five service domains: process development, scale-up, bespoke/contract production, analytical development, and environmental assessment. The company generates revenue through three principal streams: professional service fees for process development projects, transaction-based fees for contract manufacturing campaigns on BioDémo, and licensing/royalty income from proprietary technologies (notably the Futurol 2G ethanol process licensed via Axens to INA Croatia for 55,000 tonnes/year). Disclosed revenue was €24 million in fiscal year 2022, supported by approximately 130 employees and a portfolio of ~80 patents filed over 20 years.

ARD serves a dual clientele of innovative biotechnology startups (BioAmber, Fermentalg, Global Bioenergies, Wheatoéo) seeking to validate processes before building their own facilities, and established industrial groups (Amyris, Corbion, Cristal Union) needing flexible contract production capacity. End markets span renewable platform chemicals, cosmetics ingredients, food and nutrition (e.g., DHA omega-3), bio-surfactants, bio-inputs for agriculture, and second-generation biofuels. The company's go-to-market is enterprise field sales, leveraging its IAR/Bioeconomy for Change cluster membership (~400 members) and VIVESCIA cooperative network for referrals, with technical engagements led by the Directeur Général and Head of Industrialization. Notable strategic moves include the 2018 acquisition of Procethol-2G (Futurol technology), the October 2023 inauguration of BioDémo Line 2 (€8M investment, 35 new jobs), and the June 2025 Genopole partnership extending its reach to 78 additional biotech companies.

Name

ARD

Legal name

ARD

Website

https://a-r-d.fr

Company type

Private

Founded year

1989

Operating status

Operating

Headcount range

51–100 employees

Short description

ARD is a French industrial biotechnology company that provides fermentation scale-up, contract manufacturing, and green chemistry services to biotech startups and industrial firms, operating the BioDémo industrial demonstration platform (180-350 m³ fermenters) at the Pomacle-Bazancourt biorefinery as a subsidiary of VIVESCIA cooperative.

Ownership category

akta.pro rank

Product category

Industrial Biotechnology Contract Services

NAICS

Research and Development in Biotechnology (except Nanobiotechnology) (541714), Chemical Manufacturing (325)

SIC

Services-Commercial Physical & Biological Research (8731), Industrial Organic Chemicals (2860)

akta.pro primary industry

Bioprocess Development & Scale-Up/Scale-Down Platforms (DoE, high-throughput, modeling) (HLAAAJAF)

akta.pro secondary industries

Process Development & Tech Transfer Services (upstream/downstream) (HLAAAKAF), Biofuel Plant EPC, O&M & Process Technology Providers (EUAAAHAK), Cell Culture & Bioprocess Lab Equipment (Bioreactors, Single-Use Systems, Controllers) (HLAGAIAG)

Keywords

• Industrial biotechnology
• Contract manufacturing
• Process development
• Plant extraction
• Green chemistry

Headquarters

HQ city

Pomacle

HQ country

France

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure

Revenue model

1. Process Development Services: ARD provides R&D and process development services to startups and industrial companies, developing and scaling biotechnological and green chemistry processes from laboratory to industrial scale. Revenue is generated through project-based service contracts.
2. Contract Manufacturing / Bespoke Production: ARD produces molecules and products at industrial scale on behalf of clients using its BioDémo demonstration platform and pilot facilities. Clients include startups that have not yet built their own production capacity and industrial companies needing flexible production runs. Revenue is generated per production campaign or project.
3. Technology Licensing and Spin-off Companies: ARD has created and co-founded subsidiary companies (Soliance, Wheatoleo) and joint ventures (BioAmber) based on proprietary technologies. These entities generate licensing and commercial revenue streams. Additionally, the Futurol technology (developed via the Procethol-2G project) has been licensed to third parties such as INA (Croatia) via Axens.

Go-to-market motion2 records

Distribution channels4 records

Marketing channels5 records

Core offering

ARD operates as an open-innovation R&D centre and contract manufacturing services provider for industrial biotechnology. Its core offering is process development, scale-up, and bespoke/contract manufacturing of bio-based molecules using fermentation, green chemistry, and plant extraction technologies. The company bridges laboratory-scale bioprocess development and commercial production through its BioDémo industrial demonstration plant featuring fermenters up to 350 m³, enabling startups and industrial firms to validate bioprocesses and produce first industrial batches without capital investment in dedicated facilities.

Product overview

ARD operates as an open R&D center specializing in plant fractionation, white biotechnologies, and plant chemistry. The company offers an integrated portfolio of services organized around five core domains: Industrial Biotechnologies (white biotechnology using fermentation of renewable carbon), Green Chemistry (sustainable plant-based chemicals), Plant Extraction (active ingredient extraction from biomass), and an integrated services suite encompassing Process Development, Scale-Up, Bespoke Production, Analytical Development, and Environmental Services. Central to this portfolio is BioDémo, the industrial demonstration plant featuring 180-350 m³ fermenters, which enables scaling from laboratory through pilot to full industrial production. ARD serves start-ups and industrial companies seeking to develop and validate bioprocesses before committing to commercial-scale facilities.

Differentiator

Problem solved

Functional benefit

Products and services

• BioDémo Industrial Demonstration Platform Industrial demonstration plant that proves technical feasibility and viability of biotechnological processes at full industrial scale. Features fermenters of 180 m³ (line 1) and 220 m³ (line 2) with combined capacity referenced up to 350 m³. Operates 24/7 and enables clients to launch first industrial production batches while limiting risk for project sponsors.
• Process Development ARD develops unique industrial processes for clients, from simulation and process modeling through to unit operations at pilot and demonstration scale. Services include determining innovative processes and testing large-scale production for cosmetics, food, detergent, and other industry applications.
• Scale-Up Services ARD provides scale-up services to help companies transition processes from laboratory to pilot to industrial production. From protein extraction and purification to fermentation and green chemistry process development, ARD offers modular equipment to support scale-up trials.
• Bespoke/Contract Production Custom manufacturing (production à façon) services allowing start-ups and manufacturers to produce pre-marketing series with targeted sales prices. Includes unique technical feasibility studies, process validation, and risk management before full-scale production.
• Analytical Development Analytical development team performs analysis from raw materials to finished products using standardized methods and custom methodologies for complex plant compounds. Includes physico-chemical analyses (dry matter, ash, nitrogen) to establish mass balances and improve processes.
• Environmental Services Environmental assessment services including product biodegradability testing, eco-toxicity evaluation, anaerobic digestion potential, and atmospheric impact analysis to help companies analyze and improve environmental footprint of their processes.
• Industrial Biotechnologies (White Biotechnology) White biotechnologies using micro-organisms' natural synthesis abilities via fermentation on substrates to produce molecules at large scale. Applications include biofuels, green chemistry chemicals, food industry, pharmaceuticals, and solvents. ARD covers the full chain from strain identification to industrial-scale fermentation.
• Green Chemistry (Chimie Verte) Sustainable chemistry replacing fossil-based carbon molecules with renewable, biodegradable plant-based molecules. ARD develops biopolymers for bio-plastics, specialty chemicals for cosmetics and bio-control, and plant-based surfactants from sugars.
• Plant Extraction Plant extraction using enzymatic, mechanical, or thermal processes, with purification via membrane technology, ion exchange chromatography, or drying. Works with large-scale farming crops (sugar beet, wheat, barley, alfalfa), dedicated crops (miscanthus, poplar), and agri-industrial by-products to produce proteins, rare sugars, cosmetic actives, and food prototypes.
• Bioinputs Development Solutions for sustainable agriculture including screening, development, and formulation of micro-organisms, field trials, and industrial scale-up of production. ARD partners with companies to accelerate bio-pesticides, bio-stimulants, and bio-fertilizers to market.

Quantifiable outcome

• First industrial demonstration of renewable succinic acid at commercial scale (BioAmber, 2,000 tonnes/year)
• +5 more outcomes

Named customers8 records

Segments5 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature7 records

Partnerships

Eleven partnerships are on record, tiered core and minor.

• GenopolecoreStrategic or Co-development Partner · 23 June 2025ARD and Genopole (France's leading biotech biocluster) signed a 24-month renewable partnership agreement on June 23, 2025, to provide integrated strategic and operational support for biotech project sponsors seeking to industrialize. The collaboration combines Genopole's genetics and biotech research expertise (78 companies, 16 labs, 23 technology platforms) with ARD's industrial scale-up capabilities. A joint steering committee will manage the partnership, which is non-exclusive and includes IP provisions for joint vs. individual creations.
• Procethol-2GminorStrategic or Co-development Partner · 1 November 2018ARD acquired Procethol-2G's pilot platform on November 1, 2018, extending ARD's expertise in biomass pretreatment and adding new scale-up capacities for biotechnology processes. The acquisition brought 12 employees and the Futurol 2G ethanol technology to ARD. VIVESCIA and ARD were two of the eleven shareholders of Procethol-2G.
• IAR / Bioeconomy for ChangecoreStrategic or Co-development PartnerARD is an active member and founding member of the IAR (Industries et Agro-Ressources) / Bioeconomy for Change competitiveness cluster. The cluster has ~400 members including companies, startups, SMEs, large groups, R&D centres, universities, investors, and public partners. ARD participates in collaborative R&D projects and receives referrals through this ecosystem.
• Elephant Vert (NILE)coreStrategic or Co-development PartnerARD partnered with Elephant Vert to create the company NILE, focused on accelerating the industrialization, market launch, and democratization of bio-inputs (bio-pesticides, bio-stimulants, bio-fertilisers) across the entire food chain for sustainable agriculture.
• CEBB (Centre d'Excellence de Biotechnologies Blanches)minorStrategic or Co-development PartnerInaugurated December 1, 2016, CEBB is an academic excellence centre dedicated to developing new ways to create value from biomass. ARD collaborates with University of Reims Champagne Ardenne, Centrale Paris, Agro Paris Tech, and Neoma Business School through CEBB for higher education, research, and innovation.
• SolianceminorStrategic or Co-development PartnerSoliance is a former ARD subsidiary (until June 2014) specializing in active cosmetic ingredients derived from plants and microalgae. Founded in 1994, it was one of ARD's first spin-off companies and continues to operate in the cosmetics ingredients market.
• BioAmberminorStrategic or Co-development PartnerBioAmber was a joint venture between DNP Green Technology and ARD, established to develop and commercialize the world's first renewable succinic acid plant at ARD's site. ARD provided the site, process expertise, and industrial demonstration capabilities for the 2,000-tonne/year plant.
• AxensminorChannel Partner/ Reseller/ DistributorAxens is the commercial licensee of the Futurol 2nd generation ethanol technology, which ARD helped develop through Procethol-2G. Axens signed the first commercial license with INA (Croatia) for a 55,000-tonne/year 2G ethanol plant.
• University of Reims Champagne Ardenne (URCA)minorStrategic or Co-development PartnerAcademic partner collaborating through CEBB for research and higher education in white biotechnologies. ARD provides industry perspective and access to its facilities for academic projects.
• Global BioenergiesminorStrategic or Co-development PartnerARD has partnered with Global Bioenergies since 2017 for the scale-up of isobutene production via engineered bacterial fermentation. In December 2017, a second process (C3: acetone and isopropanol) was also transferred to ARD for scale-up. This partnership has produced notable achievements including the first international flight powered by renewable aviation fuel.
• FermentalgminorStrategic or Co-development PartnerARD partnered with Fermentalg to scale up production of DHA (omega-3) from microalgae. Production began at ARD's Pomacle site in January 2017, with the first batches refined and delivered to potential partners for pre-commercialization.

Scale indicators12 records

Recent moves10 records

Expansion highlights6 records

Direct peers

• Fermentalg: French microalgae-based biotechnology company producing DHA omega-3 and other ingredients via fermentation. ARD scaled Fermentalg's first DHA production campaigns at Pomacle, making it directly comparable as a French fermentation biotech in ARD's customer ecosystem.
• Carbios: French industrial biotech using engineered enzymes for PET plastic recycling and bio-based monomer production. Comparable to ARD as a French-headquartered industrial biotech developing bio-processes for sustainable chemistry and circular materials.
• Afyren: French industrial biotech producing bio-based organic acids (acetic, succinic, propionic) from non-food biomass via fermentation. Comparable to ARD as a French bioeconomy player converting biomass into renewable platform chemicals through white biotechnology processes.
• Global Bioenergies: French industrial biotechnology company developing renewable isobutene and C3 chemicals via engineered bacterial fermentation. Directly comparable to ARD as a French biotech working on bio-based platform chemicals through fermentation — and historically a customer for ARD's scale-up services.

Broad incumbents

• Ginkgo Bioworks: US-based synthetic biology platform combining organism engineering with downstream fermentation scale-up services (acquired Bioworks7 / FGen / Dutch DNA). Comparable to ARD in offering strain-to-scale bioprocess services, but at much broader scale and with an organism-engineering proprietary angle.
• Novonesis (formerly Novozymes): Global leader in industrial enzymes and microbial fermentation with extensive bioprocess development and contract manufacturing capabilities. Comparable to ARD as a major industrial biotech platform, though Novonesis is significantly larger, with global CDMO operations and a focus on enzyme products.
• Roquette: French global starch and polyol producer with an integrated biorefinery platform and growing fermentation activities (including the Roquette Beauté joint venture). Comparable to ARD as a French-rooted bioeconomy platform operating biorefinery assets, though at much larger scale and with its own commercial product portfolio rather than a CDMO model.

Emerging players

• Culture Biosciences: US-based contract fermentation services provider with cloud-monitored bioreactors from bench to pilot scale. Comparable to ARD's process development and fermentation services, but focused on smaller-scale bioreactors (up to ~250 L) and a digital-first customer experience.
• Botalys: Belgian/French plant biotech producing rare botanical actives via hydroponic and fermentation-based cultivation. Comparable to ARD's plant extraction expertise and fermentation capabilities, though focused on premium cosmetic/nutraceutical actives at smaller scale.
• Bota Bio: US/China-based industrial biotechnology company offering end-to-end biomanufacturing services from strain engineering to commercial fermentation. Comparable to ARD's integrated scale-up model for industrial fermentation, with a broader geographic footprint and emerging commercial-scale offering.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/@ardpomacle51110
• LinkedInlinkedin.com/company/a-r-d

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles7 records

Subsidiaries3 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about ARD